Mandating Exclusive Review of Individual Treatments (MERIT) Act

Fact Sheet API

Bill Number

HR 9127

Introduced

Oct 4, 2022

Latest Action

Referred to the Subcommittee on Health.

Sponsor

Cosponsors

Topics

Health Medical research Medicare Prescription drugs

Full Text

View Full Bill Text

Votes

Summary

Mandating Exclusive Review of Individual Treatments (MERIT) Act

This bill specifies that coverage determinations for drugs and biologics under Medicare must be made with respect to each drug or biologic, rather than with respect to a class of drugs or biologics.

Actions

Oct 5, 2022

Referred to the Subcommittee on Health.
Oct 4, 2022

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 4, 2022

Introduced in House

Amendments

Related Bills